Pub Date : 2020-11-01DOI: 10.1136/ijgc-2020-igcs.18
P. Harter, D. Petran, G. Scambia, E. Ortega, I. Tsibulak, S. Nagao, I. Vergote, J. Meunier, F. Priou, R. Sverdlin, T. Milenkova, I. Ray-Coquard
{"title":"18 Efficacy of maintenance olaparib plus bevacizumab by biomarker status in clinical higher- and lower-risk patients with newly diagnosed, advanced ovarian cancer in the PAOLA-1 trial","authors":"P. Harter, D. Petran, G. Scambia, E. Ortega, I. Tsibulak, S. Nagao, I. Vergote, J. Meunier, F. Priou, R. Sverdlin, T. Milenkova, I. Ray-Coquard","doi":"10.1136/ijgc-2020-igcs.18","DOIUrl":"https://doi.org/10.1136/ijgc-2020-igcs.18","url":null,"abstract":"","PeriodicalId":254448,"journal":{"name":"Oral Plenary","volume":"100 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2020-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"124604122","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2020-11-01DOI: 10.1136/ijgc-2020-igcs.1
J. Ledermann, N. Colombo, A. Oza, K. Fujiwara, M. Birrer, L. Randall, E. Poddubskaya, G. Scambia, YV Shparyk, M. Lim, J. Sohn, K. Yonemori, R. Stewart, Xijun Zhang, J. P. Smith, C. Linn, B. Monk
{"title":"1 Avelumab in combination with and/or following chemotherapy vs chemotherapy in treatment-naive patients with ovarian cancer: biomarker analyses from the phase 3 JAVELIN Ovarian 100 trial","authors":"J. Ledermann, N. Colombo, A. Oza, K. Fujiwara, M. Birrer, L. Randall, E. Poddubskaya, G. Scambia, YV Shparyk, M. Lim, J. Sohn, K. Yonemori, R. Stewart, Xijun Zhang, J. P. Smith, C. Linn, B. Monk","doi":"10.1136/ijgc-2020-igcs.1","DOIUrl":"https://doi.org/10.1136/ijgc-2020-igcs.1","url":null,"abstract":"","PeriodicalId":254448,"journal":{"name":"Oral Plenary","volume":"50 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2020-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"129429727","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2020-11-01DOI: 10.1136/ijgc-2020-igcs.16
A. A. Secord, M. Bookman, R. E. Coleman, Minh H. Dinh, N. Khandelwal, K. Benjamin, Rajesh Kamalakar, Danielle Sullivan, David Cella
{"title":"16 Quality-adjusted (QA) progression-free survival analyses of veliparib + carboplatin/paclitaxel (CP) vs CP alone in patients with newly diagnosed ovarian cancer","authors":"A. A. Secord, M. Bookman, R. E. Coleman, Minh H. Dinh, N. Khandelwal, K. Benjamin, Rajesh Kamalakar, Danielle Sullivan, David Cella","doi":"10.1136/ijgc-2020-igcs.16","DOIUrl":"https://doi.org/10.1136/ijgc-2020-igcs.16","url":null,"abstract":"","PeriodicalId":254448,"journal":{"name":"Oral Plenary","volume":"17 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2020-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"114700055","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：